Counsel patients to report symptoms of thyroid tumors (e.g., a lump in the neck, hoarseness, dysphagia, or dyspnea) to their physician [see Boxed Warning, Warnings and Precautions (5.1)]
Your provider should check labs including B12, vitamin D, and a metabolic panel at regular intervals
FDA approves oral semaglutide for type 2 diabetes, obesity indication pending The FDA has expanded oral semaglutides reach: now approved for CV risk reduction in type 2 diabetes, with an obesity indication decision expected soon
GIP receptor activation appears to enhance insulin release in a glucose-dependent manner, complementing GLP-1s effects and potentially reducing the risk of hypoglycemia in certain models
Both can potentially exacerbate this condition
Luckily, utilizing the proper technique can reduce your risk of some side effects while also limiting painful sensations